System and Method for Detection of Disease using Machine Learning

ChangeBridge: Patent Apps - Health Informatics (G16H)

Detected March 26th, 2026

Summary

The USPTO has published a new patent application (US20260088169A1) detailing systems and methods for detecting systemic disease from bacterial samples using machine learning. The application, filed by inventors Mark Driscoll and Daniel Fasulo, focuses on correlating microbiome sequence data with disease states or risk.

View original document View source feed page

What changed

This document is a USPTO patent application (US20260088169A1) for a system and method to detect systemic disease using machine learning on bacterial samples. The invention utilizes a high-throughput microbial profiling platform to diagnose disease or identify risk by correlating patient microbiome sequence data with disease states. The application was filed on September 23, 2024.

As this is a patent application, it does not impose direct regulatory obligations on healthcare providers or manufacturers. However, it signals potential future technological advancements in disease diagnostics and risk assessment. Compliance officers in the healthcare and pharmaceutical sectors should be aware of emerging technologies that may impact diagnostic tools, data analysis, and patient risk stratification in the future.

Source document (simplified)

← USPTO Patent Applications

SYSTEM AND METHOD FOR DETECTION OF DISEASE

Application US20260088169A1 Kind: A1 Mar 26, 2026

Inventors

Mark Driscoll, Daniel Fasulo

Abstract

The present invention provides systems and methods for the detection of systemic disease from bacterial content samples obtained from a subject. Also provided are methods of training a machine learning algorithm to correlate patient microbiome sequence data with a disease state or disease development risk. These systems and methods utilize a high-resolution, database-independent, high-throughput microbial profiling platform to diagnose systemic disease in patients or to identify those patients at risk of developing systemic disease. Also provided are systems and kits for carrying out the methods.